This fertility benefit business is set to boom. Buy the stock now, Wells Fargo says
First publishedAug 20, 13:16 UTC
Last updatedAug 20, 14:11 UTC · 12m ago
1 outlets over time — hover a bar for its window & outletslast updated
Answer
Progyny is set to benefit from several structural tailwinds, including catalysts that should help it court more clients, according to Wells Fargo.
Reported by 1 outlet — CNBC Top News. See all sources ↓
Read the full report at CNBC Top News ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
In brief
- What's the story?
- Progyny is set to benefit from several structural tailwinds, including catalysts that should help it court more clients, according to Wells Fargo.
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 12m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
This fertility benefit business is set to boom. Buy the stock now, Wells Fargo says
Sources1TypeCoverageCNBC Top News
Related in the knowledge graph
Sources (1)
Avg source rating 7.0/10Processing cluster
A1A2A3B1B2B3